Histogen Inc.
HSTODelisted Oct 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001383701
Histogen Inc. was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Jun 21, 2023; 9 institutions reported holding it in 13F filings for Q3 2023, worth $9.53K in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Histogen Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −2 vs. Q4 2021
- Shares held
- 4.01M
- −4.31M (−51.8%) vs. Q4 2021
- Total value
- $1.00M
- −$1.76M (−63.8%) vs. Q4 2021
- New holders
- 4
- 7 more added
- Sold out
- 6
- 4 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HSTO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $6 |
| Q4 2023 | 1 | $5 |
| Q3 2023 | 9 | $9.53K |
| Q2 2023 | 13 | $107.8K |
| Q1 2023 | 14 | $211.1K |
| Q4 2022 | 13 | $90.4K |
| Q3 2022 | 13 | $174.0K |
| Q2 2022 | 10 | $229.0K |
| Q1 2022 | 23 | $1.00M |
| Q4 2021 | 25 | $2.76M |
| Q3 2021 | 22 | $2.15M |
| Q2 2021 | 24 | $2.99M |
| Q1 2021 | 26 | $2.18M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Histogen Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 3 | $0 | 0.00% | −70−95.9% | Reduced |
| Wells Fargo & Company | 274 | $0 | 0.00% | +45+19.7% | Added |
| Morgan Stanley | 2,177 | $0 | 0.00% | +2,174+72,466.7% | Added |
| Compagnie Lombard Odier SCmA | 300 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 100 | $0 | 0.00% | +100 | New |
| Royal Bank of Canada | 300 | $0 | 0.00% | +300 | New |
| JPMorgan Chase & Co | 3,443 | $1.00K | 0.00% | +3,443 | New |
| Advisor Group Holdings, Inc. | 7,600 | $2.00K | 0.00% | −5,350−41.3% | Reduced |
| Two Sigma Advisers, LP | 14,600 | $4.00K | 0.00% | −14,400−49.7% | Reduced |
| Tower Research Capital LLC (TRC) | 33,127 | $8.00K | 0.00% | +11,080+50.3% | Added |
| Newman Dignan & Sheerar, Inc. | 52,522 | $13.0K | 0.00% | 00.0% | Unchanged |
| Synovus Financial Corp | 51,000 | $13.0K | 0.00% | +30,000+142.9% | Added |
| United Capital Financial Advisers, LLC | 79,987 | $20.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 92,228 | $23.0K | 0.00% | −44,587−32.6% | Reduced |
| Northern Trust Corp | 90,026 | $23.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 95,097 | $24.0K | 0.00% | +13,168+16.1% | Added |
| UBS Group AG | 97,044 | $24.0K | 0.00% | +62,402+180.1% | Added |
| Susquehanna International Group, LLP | 155,439 | $39.0K | 0.00% | +155,439 | New |
| State Street Corp | 172,200 | $43.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 207,794 | $51.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 698,234 | $174.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 987,924 | $247.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,167,067 | $292.0K | 0.00% | +514,387+78.8% | Added |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −4,941,178−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −51,192−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −28,837−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,982−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Tyler-Stone Wealth Management | 0 | $0 | 0.00% | −100−100.0% | Sold out |